 |
|
Antiplatelet Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
Steven P. Schulman, MD
JAMA. 2004;292:1875-1882.
ABSTRACT
Acute coronary syndromes are a frequent cause of hospital admission for patients with coronary artery disease. The pathophysiology of acute coronary syndromes often involves plaque rupture or fissure with platelet aggregation. Recognition of the importance of platelet aggregation resulted in several large randomized trials testing 3 types of platelet antagonists, aspirin, glycoprotein IIb/IIIa inhibitors, and adenosine diphosphate inhibitors. A thorough understanding of the data, risks, and benefits of these therapies is important to optimize treatment of the patient with an acute coronary syndrome. Recognition that there is a great deal of interpatient variability in response to these antiplatelet therapies highlights the need for future research in this area.
Author Affiliation: Coronary Care Unit, The Johns Hopkins Hospital, Baltimore, Md.
Corresponding Author: Steven P. Schulman, MD, Coronary Care Unit, The Johns Hopkins Hospital, 601 N Wolfe St, Carnegie 568, Baltimore, MD 21287 (sschulm{at}jhmi.edu).
RELATED LETTERS
Electrocardiographic Findings in Non–ST-Segment Elevation Myocardial Infarction
Amnon Schlegel
JAMA. 2005;293(4):423.
EXTRACT
| FULL TEXT
Electrocardiographic Findings in Non–ST-Segment Elevation Myocardial Infarction—Reply
Steven P. Schulman
JAMA. 2005;293(4):423-424.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Oral Antiplatelet Therapy in Cerebrovascular Disease, Coronary Artery Disease, and Peripheral Arterial Disease
Huyen Tran and Sonia S. Anand
JAMA. 2004;292(15):1867-1874.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial
Ndrepepa et al.
Eur Heart J 2008;29:455-461.
ABSTRACT
| FULL TEXT
Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST segment elevation acute coronary syndromes: benefit and harm in different age subgroups
Hernandez et al.
Heart 2007;93:450-455.
ABSTRACT
| FULL TEXT
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial
Kastrati et al.
JAMA 2006;295:1531-1538.
ABSTRACT
| FULL TEXT
Electrocardiographic Findings in Non-ST-Segment Elevation Myocardial Infarction
Schlegel
JAMA 2005;293:423-423.
FULL TEXT
|
